ClinicalTrials.Veeva

Menu

Volume of Perirenal Fat and Chronic Kidney Disease

C

Centre Hospitalier Universitaire de Nice

Status

Unknown

Conditions

Nephrectomy

Study type

Observational

Funder types

Other

Identifiers

NCT02870621
12-PP-06

Details and patient eligibility

About

The perirenal fat may alter renal function by secreting fibrotic inflammatory agents when accumulates during obesity. Nephrectomy for renal tumor is a model that would provide tissue samples to test this hypothesis. Renal tumor could itself be responsible for inflammation and fibrosis in its environment. This study aims to measure the influence of the tumor on his kidney Environment and fat and define molecular markers not influenced by renal tumor. The main objective is to compare the inflammation of the perirenal fat taken in two locations in the same patient, in contact and 4 cm from the outer edge of the tumor, each patient as his own control. The secondary objective is to compare the degree of interstitial fibrosis of the renal cortex in the same sampling methods.

Enrollment

12 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or more
  • Indication nephrectomy for kidney tumor
  • Stadium T1a, T1b or T2 and M0 according to the TNM (Tumor Nodes Metastasis) classification of tumors

Exclusion criteria

  • Nephrectomy indication for chronic pyelonephritis
  • Asian topic because of the difference threshold values used to characterize the metabolic syndrome in this population
  • Diabetes type I or II due to a high score of renal interstitial fibrosis
  • Infection with HIV (Human immunodeficiency virus)
  • Partial nephrectomy (a part of the kidney on the side of the tumor is left in place)

Trial contacts and locations

1

Loading...

Central trial contact

Guillaume FAVRE, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems